DocGo Inc. (NASDAQ:DCGO) Receives Average Rating of “Hold” from Analysts

Shares of DocGo Inc. (NASDAQ:DCGO) have earned an average recommendation of “Hold” from the six brokerages that are currently covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and three have given a buy recommendation to the company. The average 1-year target price among analysts that have covered the stock in the last year is $2.3750.

DCGO has been the topic of several recent research reports. Wall Street Zen upgraded DocGo from a “sell” rating to a “hold” rating in a report on Saturday, May 16th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of DocGo in a report on Thursday, June 18th. Cantor Fitzgerald reiterated an “overweight” rating on shares of DocGo in a research report on Monday, May 11th. Canaccord Genuity Group reissued a “hold” rating and set a $1.00 price objective on shares of DocGo in a research note on Tuesday, August 18th. Finally, Needham & Company LLC restated a “buy” rating and issued a $3.00 target price on shares of DocGo in a report on Tuesday, August 18th.

DocGo Trading Down 4.2%

DCGO opened at $0.38 on Tuesday. The firm has a market capitalization of $37.69 million, a PE ratio of -0.19 and a beta of 0.99. DocGo has a twelve month low of $0.35 and a twelve month high of $1.65. The firm’s 50-day moving average price is $0.57 and its 200 day moving average price is $0.61.

DocGo (NASDAQ:DCGO) last announced its quarterly earnings data on Monday, August 17th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.06). The business had revenue of $73.42 million for the quarter, compared to analysts’ expectations of $75.35 million. DocGo had a negative net margin of 65.29% and a negative return on equity of 40.42%. As a group, analysts predict that DocGo will post -0.22 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the company. Empowered Funds LLC acquired a new position in DocGo in the 2nd quarter valued at about $79,000. S Squared Technology LLC acquired a new stake in shares of DocGo during the 2nd quarter worth approximately $1,060,725. Ieq Capital LLC purchased a new stake in shares of DocGo during the 2nd quarter valued at approximately $126,000. Diversify Advisory Services LLC purchased a new stake in shares of DocGo during the 2nd quarter valued at approximately $53,000. Finally, BlackRock Inc. acquired a new position in DocGo in the second quarter valued at approximately $750,000. Institutional investors and hedge funds own 56.44% of the company’s stock.

DocGo Company Profile

DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.

In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.